NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
The prevalence of osteoarthritis (OA) notably surges with age and weight gain. The most common clinical therapeutic drugs are painkillers, yet they cannot impede the deteriorating course of OA. Thus, understanding OA’s pathogenesis and devising effective therapies is crucial. It is generally recogni...
Saved in:
Main Authors: | Yuzhou Liu, Ying Wang, Ping Yan, Ning Cui, Kejin Xu, Da Liu, Yuan Tian, Lingling Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/14/1/71 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome
by: Zhuo Liu, et al.
Published: (2025-01-01) -
Navigating from cellular phenotypic screen to clinical candidate: selective targeting of the NLRP3 inflammasome
by: Rosalie Matico, et al.
Published: (2024-12-01) -
ROLE OF THE MODULATORY MEDIATOR SEROTONIN IN THE INDUCTION OF EPIGENETIC PROCESSES DURING LONG TERM MEMORY FORMATION IN HELIX
by: L. N. Grinkevich, et al.
Published: (2015-01-01) -
Global Research Trends and Focus on the Link Between Heart Failure and NLRP3 Inflammasome: A Bibliometric Analysis From 2010 to 2024
by: Lian Y, et al.
Published: (2025-02-01) -
Bushen Huoxue formula protects against renal fibrosis and pyroptosis in chronic kidney disease by inhibiting ROS/NLRP3-mediated inflammasome activation
by: Lin Liao, et al.
Published: (2024-12-01)